1. Home
  2. HUMAW vs OTGAW Comparison

HUMAW vs OTGAW Comparison

Compare HUMAW & OTGAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

HOLD

Current Price

$0.11

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

OTGAW

OTG Acquisition Corp. I Warrants

N/A

Current Price

$0.28

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
HUMAW
OTGAW
Founded
2004
N/A
Country
United States
United States
Employees
220
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
HUMAW
OTGAW
Price
$0.11
$0.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.2K
N/A
Earning Date
03-21-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.18
N/A
52 Week High
$1.34
N/A

Technical Indicators

Market Signals
Indicator
HUMAW
OTGAW
Relative Strength Index (RSI) 38.42 N/A
Support Level $0.11 N/A
Resistance Level $0.15 N/A
Average True Range (ATR) 0.03 0.00
MACD 0.00 0.00
Stochastic Oscillator 38.78 0.00

Price Performance

Historical Comparison
HUMAW
OTGAW

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About OTGAW OTG Acquisition Corp. I Warrants

OTG Acquisition Corp I is a newly organized blank check company.

Share on Social Networks: